{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:23:54Z","timestamp":1787315034789,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Patolog\u00eda"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.patol.2026.100879","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T19:03:57Z","timestamp":1779735837000},"page":"100879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A cross-sectional study on the expression of CD44 as a stem cell marker in breast cancer patients: Association with clinicopathological prognostic markers across molecular subtypes"],"prefix":"10.1016","volume":"59","author":[{"given":"Amita","family":"Krishnappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrushikesh","family":"Kanakapura Paramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8350-3970","authenticated-orcid":false,"given":"Kalappa","family":"Prashantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamse Kameshwar","family":"Vivek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telugu Akula","family":"Narasaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patol.2026.100879_bib0160","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.patol.2026.100879_bib0165","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.patol.2026.100879_bib0170","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.patol.2026.100879_bib0175","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.58.062105.204854","article-title":"Cancer stem cells: models and concepts","volume":"58","author":"Dalerba","year":"2007","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.patol.2026.100879_bib0180","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/bjc.2011.159","article-title":"An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer","volume":"104","author":"Lee","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.patol.2026.100879_bib0185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.patol.2026.100879_bib0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0065-230X(08)60101-3","article-title":"CD44: structure, function, and association with the malignant process","volume":"71","author":"Naor","year":"1997","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.patol.2026.100879_bib0195","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc3023","article-title":"CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?","volume":"11","author":"Z\u00f6ller","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.patol.2026.100879_bib0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15537\/smj.2015.3.9622","article-title":"CD44 as a potential diagnostic tumor marker","volume":"36","author":"Basakran","year":"2015","journal-title":"Saudi Med J"},{"key":"10.1016\/j.patol.2026.100879_bib0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-013-2758-9","article-title":"CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up","volume":"143","author":"Dan","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.patol.2026.100879_bib0210","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1158\/1078-0432.CCR-06-2765","article-title":"Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series","volume":"13","author":"Desmedt","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.patol.2026.100879_bib0215","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.31557\/APJCP.2020.21.9.2561","article-title":"Predictive value of CD44 for prognosis in patients with breast cancer","volume":"21","author":"Roosta","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.patol.2026.100879_bib0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.breast.2016.07.016","article-title":"The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival","volume":"29","author":"Vasconcelos","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.patol.2026.100879_bib0225","article-title":"Synthesis of novel pyrazole carboxamides using reusable catalyst as antimicrobial agents and molecular docking studies","volume":"20","author":"Prabhudeva","year":"2019","journal-title":"Chem Data Collect"},{"key":"10.1016\/j.patol.2026.100879_bib0230","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/acs.jcim.1c00198","article-title":"Insight into the LFA-1\/SARS-CoV-2 Orf7a complex by protein\u2013protein docking, molecular dynamics, and MM-GBSA calculations","volume":"61","author":"Ongaro","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.patol.2026.100879_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BD-190409","article-title":"Role of CD44 in breast cancer","volume":"39","author":"Al-Othman","year":"2020","journal-title":"Breast Dis"},{"key":"10.1016\/j.patol.2026.100879_bib0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.peptides.2018.11.002","article-title":"Active-site directed peptide l-Phe-d-His-l-Leu inhibits angiotensin converting enzyme activity and dexamethasone-induced hypertension in rats","volume":"112","author":"Savitha","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.patol.2026.100879_bib0245","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3892\/ijmm.2017.3060","article-title":"Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor \u03b1","volume":"40","author":"Zhou","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.patol.2026.100879_bib0250","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.humpath.2007.12.003","article-title":"The clinicopathologic and prognostic significance of CD44+\/CD24\u2212\/low and CD44\u2212\/CD24+ tumor cells in invasive breast carcinomas","volume":"39","author":"Mylona","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.patol.2026.100879_bib0255","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2108","article-title":"The CD44+\/CD24\u2212 phenotype is enriched in basal-like breast tumors","volume":"10","author":"Honeth","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.patol.2026.100879_bib0260","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12282-018-0875-3","article-title":"Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer","volume":"25","author":"Louhichi","year":"2018","journal-title":"Breast Cancer"},{"key":"10.1016\/j.patol.2026.100879_bib0265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.5966\/sctm.2015-0048","article-title":"Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target","volume":"4","author":"Yan","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.patol.2026.100879_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CPath.S19615","article-title":"Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics","volume":"8","author":"Makki","year":"2015","journal-title":"Clin Med Insights Pathol"},{"key":"10.1016\/j.patol.2026.100879_bib0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-012-2271-6","article-title":"Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer","volume":"136","author":"Tsang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.patol.2026.100879_bib0280","first-page":"165","article-title":"Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients","volume":"57","author":"Horiguchi","year":"2010","journal-title":"J Med Dent Sci"},{"key":"10.1016\/j.patol.2026.100879_bib0285","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/1078-0432.1154.11.3","article-title":"Prevalence of CD44+\/CD24\u2212\/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis","volume":"11","author":"Abraham","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.patol.2026.100879_bib0290","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humpath.2011.05.005","article-title":"CD44+\/CD24\u2212 cancer stem\/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome","volume":"43","author":"Idowu","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.patol.2026.100879_bib0295","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/jclinpath-2012-201169","article-title":"Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types","volume":"66","author":"De Be\u00e7a","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.patol.2026.100879_bib0300","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.prp.2015.05.011","article-title":"The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast","volume":"211","author":"Kapucuo\u011flu","year":"2015","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.patol.2026.100879_bib0305","doi-asserted-by":"crossref","first-page":"58","DOI":"10.31768\/2312-8852.2015.37(1):58-63","article-title":"CD44+\/CD24\u2212 markers of cancer stem cells in patients with breast cancer of different molecular subtypes","volume":"37","author":"Chekhun","year":"2015","journal-title":"Exp Oncol"},{"key":"10.1016\/j.patol.2026.100879_bib0310","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.prp.2014.03.005","article-title":"Expression of cancer stem cell markers in basal and penta-negative breast carcinomas \u2013 a study of a series of triple-negative tumors","volume":"210","author":"De Medeiros","year":"2014","journal-title":"Pathol Res Pract"}],"container-title":["Revista Espa\u00f1ola de Patolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699885526000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699885526000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:37:48Z","timestamp":1787312268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699885526000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1699885526000243"],"URL":"https:\/\/doi.org\/10.1016\/j.patol.2026.100879","relation":{},"ISSN":["1699-8855"],"issn-type":[{"value":"1699-8855","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cross-sectional study on the expression of CD44 as a stem cell marker in breast cancer patients: Association with clinicopathological prognostic markers across molecular subtypes","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Patolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.patol.2026.100879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Anatom\u00eda Patol\u00f3gica. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100879"}}